Revenues (Tables)
|
6 Months Ended |
Jun. 30, 2021 |
|---|
| Revenues |
|
| Schedule of revenues disaggregated by category |
Revenues disaggregated by category were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
June 30, |
|
June 30, |
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Product sales: |
|
|
|
|
|
|
|
|
|
|
|
|
Gross product sales |
|
$ |
22,037 |
|
$ |
18,353 |
|
$ |
38,146 |
|
$ |
33,724 |
Discounts and allowances |
|
|
(4,984) |
|
|
(3,379) |
|
|
(8,717) |
|
|
(6,070) |
Total product sales, net |
|
|
17,053 |
|
|
14,974 |
|
|
29,429 |
|
|
27,654 |
Revenues from collaborations: |
|
|
|
|
|
|
|
|
|
|
|
|
License revenues |
|
|
3,305 |
|
|
— |
|
|
67,923 |
|
|
39,858 |
Research and development services and others |
|
|
408 |
|
|
1,047 |
|
|
1,432 |
|
|
4,270 |
Total revenues from collaborations |
|
|
3,713 |
|
|
1,047 |
|
|
69,355 |
|
|
44,128 |
Government contract |
|
|
5,500 |
|
|
— |
|
|
8,500 |
|
|
— |
Total revenues |
|
$ |
26,266 |
|
$ |
16,021 |
|
$ |
107,284 |
|
$ |
71,782 |
|
| Schedule of revenues from product sales disaggregated by customers |
The following table summarizes the percentages of revenues from each of our customers who individually accounted for 10% or more (wherein * denotes less than 10%) of the total net product sales and revenues from collaborations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
June 30, |
|
June 30, |
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
ASD Healthcare and Oncology Supply |
|
|
36% |
|
|
47% |
|
|
13% |
|
|
20% |
McKesson Specialty Care Distribution Corporation |
|
|
33% |
|
|
41% |
|
|
13% |
|
|
16% |
Lilly |
|
|
16% |
|
|
— |
|
|
65% |
|
|
— |
Cardinal Healthcare |
|
|
13% |
|
|
* |
|
|
* |
|
|
* |
Grifols |
|
|
* |
|
|
* |
|
|
* |
|
|
61% |
|
| Schedule of product revenue allowance and reserve categories |
The following table summarizes activity in each of the product revenue allowance and reserve categories for the six months ended June 30, 2021 and 2020 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance at January 1, 2021 |
|
$ |
2,461 |
|
$ |
2,115 |
|
$ |
1,489 |
|
$ |
6,065 |
Provision related to current period sales |
|
|
4,589 |
|
|
2,710 |
|
|
483 |
|
|
7,782 |
Credit or payments made during the period |
|
|
(4,800) |
|
|
(2,433) |
|
|
(293) |
|
|
(7,526) |
Balance at June 30, 2021 |
|
$ |
2,250 |
|
$ |
2,392 |
|
$ |
1,679 |
|
$ |
6,321 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance at January 1, 2020 |
|
$ |
1,293 |
|
$ |
1,801 |
|
$ |
238 |
|
$ |
3,332 |
Provision related to current period sales |
|
|
3,381 |
|
|
1,747 |
|
|
128 |
|
|
5,256 |
Adjustment related to prior period sales |
|
|
(75) |
|
|
(257) |
|
|
332 |
|
|
— |
Credit or payments made during the period |
|
|
(2,615) |
|
|
(1,593) |
|
|
(58) |
|
|
(4,266) |
Balance at June 30, 2020 |
|
$ |
1,984 |
|
$ |
1,698 |
|
$ |
640 |
|
$ |
4,322 |
|